tiprankstipranks

James L. Tyree Insider Profile

11 Followers
James L. Tyree, Director at Innoviva, holds 9.71K shares in Genelux Corp. (Ticker: GNLX), holds 188.25K shares in Assertio Therapeutics (Ticker: ASRT), holds 0.00 shares in ChemoCentryx (Ticker: CCXI).
tipranks
James L. Tyree

James L. Tyree
Innoviva (INVA)
Director

Ranked #33,013 out of 97,944 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+38.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$15M
94.56%
3.71%
1.59%
0.13%
A breakdown of James L. Tyree's holdings

Insider Roles

Abbott Laboratories
(ABT)
EVP
Innoviva
(INVA)
Director
Assertio Therapeutics
(ASRT)
Director
Genelux Corp.
(GNLX)
Director
Roles that James L. Tyree holds in companies

Most Profitable Insider Trade

Stock:
Genelux Corp.
(GNLX)
Rating:Informative Sell
Date:Dec 14, 2023 - Today
Return:+86.80%
The most profitable trade made by James L. Tyree

James L. Tyree's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Innoviva
Apr 24, 2017
Director
Uninformative Buy
$544.18K
Assertio Therapeutics
Mar 15, 2024
Director
Informative Sell
11.38K
$233.43K
Genelux Corp.
Jun 07, 2024
Director
Uninformative Buy
$18.93K
CCXI
ChemoCentryx
Oct 24, 2022
Uninformative Sell
$0.00
Abbott Laboratories
Mar 03, 2009
EVP
Uninformative Sell
843.06K
$13.86M
List of latest transactions for each holding click on a transaction to see James L. Tyree's performance on stock

James L. Tyree insider profile FAQ

What is the percentage of profitable transactions made by James L. Tyree?
The percentage of profitable transactions made by James L. Tyree is 50%.
    What is the average return per transaction made by James L. Tyree?
    The average return per transaction made by James L. Tyree is 38.00%.
      What stocks does James L. Tyree hold?
      James L. Tyree holds: INVA, ASRT, GNLX, CCXI, ABT stocks.
        What was James L. Tyree’s latest transaction?
        James L. Tyree latest transaction was an Uninformative Buy of ―.
          What was James L. Tyree's most profitable transaction?
          James L. Tyree’s most profitable transaction was an Informative Sell of GNLX stock on December 14, 2023. The return on the trade was 86.80%.
            What is James L. Tyree's role in Innoviva?
            James L. Tyree's role in Innoviva is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.